Search Results - "Sahm F"

WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours.

Authors: Sahm, F. Reuss, D. E. Giannini, C.

Source: Neuropathology & Applied Neurobiology. Feb2018, Vol. 44 Issue 2, p163-171. 9p.

BRAF V600 E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma.

Authors: Koelsche, C. Sahm, F. Paulus, W. et al.

Source: Neuropathology & Applied Neurobiology. Jun2014, Vol. 40 Issue 3, p337-344. 8p.

Analysis of CIC-associated CpG island methylation in oligoastrocytoma.

Authors: Sahm, F. Lass, U. Herold‐Mende, C. et al.

Source: Neuropathology & Applied Neurobiology. Dec2013, Vol. 39 Issue 7, p831-836. 6p.

Scientific correspondence.

Authors: Pusch, S. Sahm, F. Meyer, J. et al.

Source: Neuropathology & Applied Neurobiology. Jun2011, Vol. 37 Issue 4, p428-430. 3p. 1 Graph.

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.

Authors: Abu Hejleh, AP Huck, K Jähne, K et al.

Source: International Journal of Tryptophan Research. 2/9/2023, p1-11. 11p.

Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.

Authors: Wick, A. Sander, A. Koch, M. et al.

Source: BMC Cancer. Dec2022, Vol. 22 Issue 1, p1-8. 8p.

Atypical NMDA Receptor Expression in a Diffuse Astrocytoma, MYB- or MYBL1-Altered as a Trigger for Autoimmune Encephalitis.

Authors: Nikolaus, M. Koch, A. Stenzel, W. et al.

Source: Neuropediatrics. 2023 Supplement 1, Vol. 54, pS1-S32. 32p.

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.

Authors: Le Rhun, E. Guckenberger, M. Smits, M. et al.

Source: Annals of Oncology. Nov2021, Vol. 32 Issue 11, p1332-1347. 16p.

Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity.

Authors: Baumgarten, P. Harter, P. N. Tönjes, M. et al.

Source: Neuropathology & Applied Neurobiology. Apr2014, Vol. 40 Issue 2, p205-216. 13p.

GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.

Authors: Livingstone, E. Zaremba, A. Horn, S. et al.

Source: British Journal of Dermatology. Nov2020, Vol. 183 Issue 5, p928-939. 12p.

769P The prognostic impact of CDKN2A/B heterozygous deletions in meningioma-insights of a multicenter analysis.

Authors: Ippen, F.M. Hielscher, T. Patel, A. et al.

Source: Annals of Oncology. 2024 Supplement 4, Vol. 35, pS1688-S1688. 1p.

482P The prognostic impact of CDKN2A/B heterozygous deletions in meningioma: Insights of a multicenter analysis.

Authors: Ippen, F.M. Hielscher, T. Patel, A. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS421-S421. 1p.

444O The prognostic impact of CDKN2A/B heterozygous deletions in IDH-mutant glioma.

Authors: Ippen, F.M. Hielscher, T. Göbel, K. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS407-S407. 1p.

Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas.

Authors: Feller, C. Felix, M. Weiss, T. et al.

Source: Acta Neuropathologica. Jan2020, Vol. 139 Issue 1, p211-213. 3p.

Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia‐oculomotor apraxia 4 and pilocytic astrocytoma.

Authors: Scholz, C. Golas, M. M. Weber, R. G. et al.

Source: Clinical Genetics. Jul2018, Vol. 94 Issue 1, p185-186. 3p. 1 Diagram.

Voxel-accurate MRI-microscopy Correlation Enables AI-powered Prediction of Brain Disease States.

Authors: Schroers J Yang Y Reyhan E et al.

Source: Theranostics [Theranostics] 2026 Mar 17; Vol. 16 (10), pp. 5440-5462. Date of Electronic Publication: 2026 Mar 17 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.

Authors: Jungwirth G Cao J Pan Y et al.

Source: Science translational medicine [Sci Transl Med] 2026 Mar 04; Vol. 18 (839), pp. eaea3115. Date of Electronic Publication: 2026 Mar 04.

Publication Type: Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

[¹⁷⁷Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial.

Authors: Albert NL Tabouret E Le Rhun E et al.

Corporate Authors: Albert NL Tabouret E Le Rhun E et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jan 02; Vol. 67 (1), pp. 23-30. Date of Electronic Publication: 2026 Jan 02.

Publication Type: Journal Article; Clinical Trial Protocol; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma.

Authors: Kourtesakis A Bailey E Chow HNH et al.

Source: Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2518631. Date of Electronic Publication: 2025 Jun 15.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.

Authors: Apfelbaum AA Morin E Sturm D et al.

Source: Nature communications [Nat Commun] 2025 Oct 09; Vol. 16 (1), pp. 8970. Date of Electronic Publication: 2025 Oct 09.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; In Process